Under construction – not a live service
Sign in
Taking people in DenmarkNo phase

Tests a questionnaire-guided care plan for late effects in cancer survivors

Tests a patient questionnaire and follow-up plan for late effects after cancer treatment.

Plain-language title generated from the registry record
Registry title: FRAME - Implementation of a PRO Measure to Inform Patient-Centered Survivorship Care in Oncology Outpatient Visits

Key facts

Where
Vejle, DenmarkSee the site

Where in Denmark

  • Department of Oncology Vejle Hospital, University Hospital of Southern DenmarkVejle, DenmarkTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Vejle Hospital
Trial code
NCT07281820
Record updated
15 December 2025
Original description
FRAME is a patient-centered survivorship care model embedded in routine oncology visits. It consists of: (1) a pre-visit patient-reported questionnaire (FRAME-PRO), (2) a clinician-patient dialogue guided by the responses, and (3) a tailored management plan including stepped-care referrals (general practitioner and municipality; oncology department supportive services; specialized late-effects clinics). The implementation is evaluated with the RE-AIM framework supplemented by Proctor implementation outcomes. Data sources include the "Mit Sygehus" app, departmental registries, purpose-built questionnaires, fidelity checklists, and qualitative interviews with clinicians, patients, and informal caregivers.Read full original descriptionShow less

FRAME (Focused Recognition, Assessment and Management of Late Effects): A Single-Center Implementation Study Using RE-AIM to Guide Evaluation in the Department of Oncology, Vejle Hospital

FRAME is a patient-centered survivorship care model embedded in routine oncology visits. It consists of: (1) a pre-visit patient-reported questionnaire (FRAME-PRO), (2) a clinician-patient dialogue guided by the responses, and (3) a tailored management plan including stepped-care referrals (general practitioner and municipality; oncology department supportive services; specialized late-effects clinics). The implementation is evaluated with the RE-AIM framework supplemented by Proctor implementation outcomes. Data sources include the "Mit Sygehus" app, departmental registries, purpose-built questionnaires, fidelity checklists, and qualitative interviews with clinicians, patients, and informal caregivers.

Inclusion: All oncologists conducting outpatient visits at the Department of Oncology, Vejle Hospital during the study period.

Exclusion: None; Participants for interviews:; A purposive sample of patients, informal caregivers, and clinicians approached ≥6 months after launch; written and verbally informed consent.

ClinicalTrials.gov NCT07281820